JPRN-C000000271已完成2 期
A phase II study of cisplatin with TS-1 for patients with cancer of primary unknown - A phase II study of cisplatin with TS-1
Department of Medical Oncology, Kinki University School of Medicine0 个研究点目标入组 45 人开始时间: 2005年10月31日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 45
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 99years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •The exclusion criteria are as follows: 1.female adenocarcinoma with axillary lymph nodes swelling only, or pelvic cavity endolymph nodes only 2.squamous carcinoma with cervical lymph nodes swelling only, or inguen lymph nodes only 3.patients with germ cell tumor or have characteristic of neuroendocrine tumor 4.patients with high level of PSA in serum or tumor (1) severe infection or other severe complications (such as gastrointestinal bleeding, heart disease) (2) symptomatic brain metastasis (3) patients who carried out bone marrow transplantation (4) patients who carried out peripheral blood stem cell transplantation (5) drug allergy (6) pregnancy or lactating (7) male patients who hope for pregnancy (8) uncontrollable diabetes mellitus
研究者
相似试验
已完成
2 期
A randomized phase II study of cisplatin+TS-1 versus cisplatin+docetaxel, with thoracic radiotherapy for locally advanced non-small cell lung cancer (TORG1018)on-small cell lung cancerJPRN-UMIN000005993Thoracic Oncology Research Group110
已完成
2 期
Phase II trial of TS-1 and cisplatin in patients with Carcinoma of Unknown Primary Sites (KMOG 0607)Carcinoma of Unknown Primary SitesJPRN-UMIN000001364Kyushu Medical Oncology Group38
已完成
2 期
A randomized phase II study of TS-1+Cisplatin versus Vinorelbine+Cisplatin,with thoracic radiotherapy for locally advanced non-small cell lung cancer.on-small cell lung cancerJPRN-UMIN000002420West Japan Oncology Group110
已完成
2 期
A randomized phase II study of Cisplatin plus S-1 versus Cisplatin plus Pemetrexed, with thoracic radiotherapy for locally advanced non-squamous non-small cell lung cancerJPRN-UMIN000009914ational Cancer Center Hospital East100
已完成
2 期
A phase II study of S-1 plus cisplatin with concurrent radiation for locally advanced thymic carcinoma (LOGIK1605/JART-1501)Thymic carcinomaJPRN-UMIN000024643Clinical Research Support Center Kyushu30